Holen Sie sich die Stockscreener-App
2.41
5.24%
0.12
Vorhandelsmarkt:
2.39
-0.02
-0.83%
Schlusskurs vom Vortag:
$2.29
Offen:
$2.29
24-Stunden-Volumen:
961.69K
Relative Volume:
0.67
Marktkapitalisierung:
$416.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.70M
KGV:
-7.303
EPS:
-0.33
Netto-Cashflow:
$-51.36M
1W Leistung:
+5.24%
1M Leistung:
+16.99%
6M Leistung:
-13.00%
1J Leistung:
-47.84%
1-Tages-Spanne:
$2.28
$2.42
1-Wochen-Bereich:
$2.25
$2.42
52-Wochen-Spanne:
$1.89
$4.74
Savara Inc Stock (SVRA) Company Profile
Firmenname
Savara Inc
Sektor
Branche
Telefon
51285113796
Adresse
6836 BEE CAVE ROAD, AUSTIN, TX
Vergleichen Sie SVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
2.41 | 395.80M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-13 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-07 | Eingeleitet | Guggenheim | Buy |
| 2023-05-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-03-31 | Herabstufung | Jefferies | Buy → Hold |
| 2021-03-16 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-15 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Fortgesetzt | ROTH Capital | Neutral |
| 2018-01-03 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-09-27 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-22 | Eingeleitet | Jefferies | Buy |
| 2017-09-11 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Savara Inc Aktie (SVRA) Neueste Nachrichten
Analysts Set Savara Inc. (NASDAQ:SVRA) PT at $5.60 - Defense World
Savara Inc. Stock Analysis and ForecastTurbocharged investment results - jammulinksnews.com
Savara's Path to Overcoming the FDA RTF for MOLBREEVI and Reclaiming aPAP Market Leadership - AInvest
What analysts say about Savara Inc. stockDynamic capital growth - jammulinksnews.com
Savara: Repairing The Molbreevi aPAP Opportunity After RTF (NASDAQ:SVRA) - Seeking Alpha
What drives Savara Inc. stock priceBreakout stock performance - jammulinksnews.com
Is Savara Inc. a good long term investmentTurbocharged investment results - jammulinksnews.com
Savara Inc. Grants Inducement Awards to New Employees with Stock Options & RSUs - MyChesCo
How Savara Inc. stock reacts to Fed policy changesTrend Following Trades - Newser
Savara Inc. Announces Equity Awards for New Employees - MSN
Savara Announces New Employment Inducement Grant - The Globe and Mail
What makes Savara Inc. stock price move sharplyTrade With Low Risk Exposure - Newser
How Savara Inc. stock performs during market volatilityPortfolio Boosting Stock Alerts - Newser
Why Savara Inc. stock attracts strong analyst attentionControlled Risk High Reward Plan - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc.SVRA - ETX View
Savara's Mysterious 7% Surge: A Technical Deep Dive - AInvest
Savara Inc.(NasdaqGS: SVRA) dropped from Russell 3000E Value Index - MarketScreener
Savara Inc: director Hawkins buys $98k in shares - Investing.com
Insiders Who Purchased US$783.7k Of Savara Stock May Not Have Expected 12% Tumble - simplywall.st
Savara’s SWOT analysis: biotech firm’s stock poised for growth with aPAP drug - Investing.com India
Savara Inc (NASDAQ:SVRA) Stake Reduced by California State Teachers Retirement System - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $482,000 Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Sold by Bank of America Corp DE - Defense World
Ameriprise Financial Inc. Takes Position in Savara Inc (NASDAQ:SVRA) - Defense World
Jane Street Group LLC Decreases Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
savara elects board members and approves proposals at annual meeting - Investing.com Australia
savara elects board members and approves proposals at annual meeting By Investing.com - Investing.com South Africa
Finanzdaten der Savara Inc-Aktie (SVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):